123 related articles for article (PubMed ID: 12883468)
21. Tetrahydrobiopterin increases insulin sensitivity in patients with type 2 diabetes and coronary heart disease.
Nyström T; Nygren A; Sjöholm A
Am J Physiol Endocrinol Metab; 2004 Nov; 287(5):E919-25. PubMed ID: 15265759
[TBL] [Abstract][Full Text] [Related]
22. Reactive species and early manifestation of insulin resistance in type 2 diabetes.
Fridlyand LE; Philipson LH
Diabetes Obes Metab; 2006 Mar; 8(2):136-45. PubMed ID: 16448517
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular risk in the spectrum of type 2 diabetes mellitus.
Ahmed I; Goldstein BJ
Mt Sinai J Med; 2006 Sep; 73(5):759-68. PubMed ID: 17008936
[TBL] [Abstract][Full Text] [Related]
24. Cardiovascular metabolic syndrome - an interplay of, obesity, inflammation, diabetes and coronary heart disease.
Rana JS; Nieuwdorp M; Jukema JW; Kastelein JJ
Diabetes Obes Metab; 2007 May; 9(3):218-32. PubMed ID: 17391148
[TBL] [Abstract][Full Text] [Related]
25. Modulation of the myocardial redox state by vagal nerve stimulation after experimental myocardial infarction.
Tsutsumi T; Ide T; Yamato M; Kudou W; Andou M; Hirooka Y; Utsumi H; Tsutsui H; Sunagawa K
Cardiovasc Res; 2008 Mar; 77(4):713-21. PubMed ID: 18065771
[TBL] [Abstract][Full Text] [Related]
26. Sweet heart - contributions of metabolism in the development of heart failure in diabetes mellitus.
Stratmann B; Tschoepe D
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S40-5. PubMed ID: 18777453
[TBL] [Abstract][Full Text] [Related]
27. Site specific changes of redox metabolism in adipose tissue of obese Zucker rats.
Galinier A; Carriere A; Fernandez Y; Caspar-Bauguil S; Periquet B; Periquet A; Penicaud L; Casteilla L
FEBS Lett; 2006 Nov; 580(27):6391-8. PubMed ID: 17098232
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance, diabetes and cardiovascular risk: approaches to treatment.
Rosenberg DE; Jabbour SA; Goldstein BJ
Diabetes Obes Metab; 2005 Nov; 7(6):642-53. PubMed ID: 16219008
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide signaling in the cardiovascular system: implications for heart failure.
Saraiva RM; Hare JM
Curr Opin Cardiol; 2006 May; 21(3):221-8. PubMed ID: 16601461
[TBL] [Abstract][Full Text] [Related]
30. Metabolic stress in insulin's target cells leads to ROS accumulation - a hypothetical common pathway causing insulin resistance.
Eriksson JW
FEBS Lett; 2007 Jul; 581(19):3734-42. PubMed ID: 17628546
[TBL] [Abstract][Full Text] [Related]
31. Metabolic syndrome: diabetes and cardiovascular disease.
Gupta S; Gupta BM
Indian Heart J; 2006; 58(2):149-52. PubMed ID: 18989060
[TBL] [Abstract][Full Text] [Related]
32. Oxidative stress and nitric oxide synthase in skeletal muscles of rats with post-infarction, compensated chronic heart failure.
Rush JW; Green HJ; Maclean DA; Code LM
Acta Physiol Scand; 2005 Nov; 185(3):211-8. PubMed ID: 16218926
[TBL] [Abstract][Full Text] [Related]
33. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy.
Wold LE; Ceylan-Isik AF; Ren J
Acta Pharmacol Sin; 2005 Aug; 26(8):908-17. PubMed ID: 16038622
[TBL] [Abstract][Full Text] [Related]
34. Transient reduction in myocardial free oxygen radical levels is involved in the improved cardiac function and structure after long-term allopurinol treatment initiated in established chronic heart failure.
Mellin V; Isabelle M; Oudot A; Vergely-Vandriesse C; Monteil C; Di Meglio B; Henry JP; Dautreaux B; Rochette L; Thuillez C; Mulder P
Eur Heart J; 2005 Aug; 26(15):1544-50. PubMed ID: 15872033
[TBL] [Abstract][Full Text] [Related]
35. Effects of insulin resistance on endothelial progenitor cells and vascular repair.
Cubbon RM; Kahn MB; Wheatcroft SB
Clin Sci (Lond); 2009 Aug; 117(5):173-90. PubMed ID: 19630751
[TBL] [Abstract][Full Text] [Related]
36. Myocardial glucose transport and utilization: a target for therapeutic intervention.
Singh PP; Lago RM; Nesto RW
Rev Cardiovasc Med; 2008; 9(2):106-10. PubMed ID: 18660731
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
38. [Oxidative stress and its effects on insulin resistance and pancreatic beta-cells dysfunction: relationship with type 2 diabetes mellitus complications].
Lopes JP; Oliveira SM; Soares Fortunato J
Acta Med Port; 2008; 21(3):293-302. PubMed ID: 18674421
[TBL] [Abstract][Full Text] [Related]
39. The usefulness of the International Diabetes Federation and the National Cholesterol Education Program's Adult Treatment Panel III definitions of the metabolic syndrome in predicting coronary heart disease in subjects with type 2 diabetes.
Tong PC; Kong AP; So WY; Yang X; Ho CS; Ma RC; Ozaki R; Chow CC; Lam CW; Chan JC; Cockram CS
Diabetes Care; 2007 May; 30(5):1206-11. PubMed ID: 17259472
[TBL] [Abstract][Full Text] [Related]
40. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
